Rheumatic Heart Disease: Pathogenesis and Vaccine

Author(s): L. Guilherme*, S. Freschi de Barros, K.F. Kohler, S.R. Santos, F. Morais Ferreira, W.R. Silva, R. Alencar, E. Postol, J. Kalil

Journal Name: Current Protein & Peptide Science

Volume 19 , Issue 9 , 2018

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Rheumatic fever (RF) and rheumatic heart disease (RHD) follow untreated S. pyogenes throat infections in children who present susceptible genes that favor the development of autoimmune reactions. In this review, we focus on the genes that confer susceptibility and on the autoimmune reactions that occur due to molecular mimicry between human-tissue proteins and streptococcal M protein. Polyarthritis is the initial manifestation, which can evolve to carditis and severe valve damage; these culminate in rheumatic heart disease (RHD) or Sydenham’s chorea, which affects the central nervous system. A perspective on vaccine development to prevent the disease is also discussed.

Keywords: Rheumatic fever, rheumatic heart disease, M protein, genes, cytokines, T and B lymphocytes, heart-tissue proteins, anti-S. pyogenes vaccine.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 25 July, 2017
Page: [900 - 908]
Pages: 9
DOI: 10.2174/1389203718666170725115855
Price: $65

Article Metrics

PDF: 48
HTML: 16
PRC: 1